Beck, AT, Brown, G, Epstein, N, Steer, RA (1988). An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology 56, 893–897.
Beck, AT, Ward, CH, Mendelson, M, Mock, J, Erbaugh, J (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 561–571.
Cannon, TD, Huttunen, MO, Dahlstrom, M, Larmo, I, Rasanen, P, Juriloo, A (2002). Antipsychotic drug treatment in the prodromal phase of schizophrenia. American Journal of Psychiatry 159, 1230–1232.
Coddington, RD (1972). The significance of life events as etiological factors in the diseases of children. II. A study of a normal population. Journal of Psychosomatic Research 16, 205–213.
Cohen, S, Kamarck, T, Mermelstein, R (1983). A global measure of perceived stress. Journal of Health and Social Behavior 24, 386–396.
Collip, D, Nicolson, NA, Lardinois, M, Lataster, T, van Os, J, Myin-Germeys, I; G.R.O.U.P. (2011). Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychological Medicine 41, 2305–2315.
Corcoran, CM, Kimhy, D, Stanford, A, Khan, S, Walsh, J, Thompson, J, Schobel, S, Harkavy-Friedman, J, Goetz, R, Colibazzi, T, Cressman, V, Malaspina, D (2008). Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophrenia Research 106, 286–293.
Corcoran, C, Smith, C, McLaughlin, D, Auther, AM, Malaspina, D, Cornblatt, BA (2012). HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia. Schizophrenia Research 135, 170–174.
Corcoran, C, Walker, E, Huot, R, Mittal, V, Tessner, K, Kestler, L, Malaspina, D (2003). The stress cascade and schizophrenia: etiology and onset. Schizophrenia Bulletin 29, 671–692.
Cornblatt, BA, Lencz, T, Smith, CW, Olsen, R, Auther, AM, Nakayama, E, Lesser, ML, Tai, JY, Shah, MR, Foley, CA, Kane, JM, Correll, CU (2007). Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. Journal of Clinical Psychiatry 68, 546–547.
Dohrenwend, BP (2006). Inventorying stressful life events as risk factors for psychopathology: toward resolution of the problem of intracategory variability. Psychological Bulletin 132, 477–495.
Goldstone, E, Farhall, J, Ong, B (2011). Life hassles, experiential avoidance and distressing delusional experiences. Behaviour Research and Therapy 49, 260–266.
Grace, AA (2012). Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia. Neuropharmacology 62, 1342–1348.
Hawkins, KA, McGlashan, TH, Quinlan, D, Miller, TJ, Perkins, DO, Zipursky, RB, Addington, J, Woods, SW (2004). Factorial structure of the scale of prodromal symptoms. Schizophrenia Research 68, 339–347.
Khalili-Mahani, N, Dedovic, K, Engert, V, Pruessner, M, Pruessner, JC (2010). Hippocampal activation during a cognitive task is associated with subsequent neuroendocrine and cognitive responses to psychological stress. Hippocampus 20, 323–334.
Kimhy, D, Corcoran, C (2008). Use of Palm computer as an adjunct to cognitive-behavioural therapy with an ultra-high-risk patient: a case report. Early Intervention in Psychiatry 2, 234–241.
Lee, H, Schepp, K (2009). The relationship between symptoms and stress in adolescents with schizophrenia. Issues in Mental Health Nursing 30, 736–744.
Liang, KY, Zeger, SL (1986). Longitudinal data analysis using generalized linear models. Biometrika 73, 13–22.
Malla, RM, Norman, RM (1992). Relationship of major life events and daily stressors to symptomatology in schizophrenia. Journal of Nervous and Mental Disease 180, 664–667.
Mason, O, Startup, M, Halpin, S, Schall, U, Conrad, A, Carr, V (2004). Risk factors for transition to first episode psychosis among individuals with ‘at-risk mental states’. Schizophrenia Research 71, 227–237.
McGorry, PD, Yung, AF, Phillips, LJ, Yuen, HP, Francey, S, Cosgrave, EM, Germano, D, Bravin, J, McDonald, T, Blair, A, Adlard, S, Jackson, H (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry 59, 921–928.
Miller, TJ, McGlashan, TH, Rosen, JL, Cadenhead, K, Ventura, J, McFarlane, W, Perkins, DO, Pearlson, GD, Woods, SW (2003). Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 29, 703–715.
Moghaddam, B (2002). Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biological Psychiatry 51, 775–787.
Monroe, SM (2008). Modern approaches to conceptualizing and measuring human life stress. Annual Review of Clinical Psychology 4, 33–52.
Morrison, AP, French, P, Walford, L, Lewis, SW, Kilcommons, A, Green, J, Parker, S, Bentall, RP (2004). Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. British Journal of Psychiatry 185, 291–297.
Norman, RM, Malla, AK (1993). Stressful life events and schizophrenia. I: A review of the research. British Journal of Psychiatry 162, 161–166.
Norman, RM, Malla, AK (1994). A prospective study of daily stressors and symptomatology in schizophrenic patients. Social Psychiatry and Psychiatric Epidemiology 29, 244–249.
Nuechterlein, KH, Dawson, ME (1984). A heuristic vulnerability/stress model of schizophrenia. Schizophrenia Bulletin 10, 300–312.
Pruessner, M, Iyer, SN, Faridi, K, Joober, R, Malla, AK (2011). Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Schizophrenia Research 129, 29–35.
Raune, D, Bebbington, P, Dunn, G, Kuipers, E (2006). Event attributes and the content of psychotic experiences in first-episode psychosis. Psychological Medicine 36, 221–230.
Schlosser, DA, Jacobson, S, Chen, Q, Sugar, CA, Niendam, TA, Li, G, Bearden, CE, Cannon, TD (2011). Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophrenia Bulletin. Published online: 8 August 2011. doi:10.1093/schbul/sbr098.
Schobel, SA, Lewandowski, NM, Corcoran, CM, Moore, H, Brown, T, Malaspina, D, Small, SA (2009). Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Archives of General Psychiatry 66, 938–946.
Steele, GP, Henderson, S, Duncan-Jones, P (1980). The reliability of reporting adverse experiences. Psychological Medicine 10, 301–306.
Tessner, KD, Mittal, V, Walker, EF (2011). Longitudinal study of stressful life events and daily stressors among adolescents at high risk for psychotic disorders. Schizophrenia Bulletin 37, 432–441.
Thompson, KN, Phillips, LJ, Komesaroff, P, Yuen, HP, Wood, SJ, Pantelis, C, Velakoulis, D, Yung, AR, McGorry, PD (2007). Stress and HPA-axis functioning in young people at ultra high risk for psychosis. Journal of Psychiatric Research 41, 561–569.
Tso, IF, Grove, TB, Taylor, SF (2012). Self-assessment of psychological stress in schizophrenia: preliminary evidence of reliability and validity. Psychiatry Research 195, 39–44.
Walker, EF, Brennan, PA, Esterberg, M, Brasfield, J, Pearce, B, Compton, MT (2010). Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth. Journal of Abnormal Psychology 119, 401–408.
Walker, EF, Cornblatt, BA, Addington, J, Cadenhead, KS, Cannon, TD, McGlashan, TH, Perkins, PO, Seidman, LJ, Tsuang, MT, Woods, SW, Heinssen, R (2009). The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophrenia Research 115, 50–57.
Walker, EF, Diforio, D (1997). Schizophrenia: a neural diathesis-stress model. Psychological Review 104, 667–685.
Webster, MJ, Knable, MB, O'Grady, J, Orthmann, J, Weickert, CS (2002). Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry 7, 985–994.
Yung, AR, Yuen, HP, McGorry, PD, Phillips, LJ, Kelly, D, Dell'Olio, M, Francey, SM, Cosgrave, EM, Kilackey, E, Stanford, C, Godfrey, K, Buckby, J (2005). Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Australian and New Zealand Journal of Psychiatry 39, 964–971.